AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2023 Issue 4; New/Revised ICD-10-PCS Codes Section X – New Technology

Transfusion of New Therapeutic Substances

Effective October 1, 2023, new values were added to table XW1, Transfusion of Anatomical Regions, for the substance H Lovotibeglogene autotemcel (lovo-cel). This change results in two new codes that capture administration of the gene therapy into the peripheral and central veins.Body Part Approach Device/Substance/ Technology Qualifier 3 Peripheral Vein 4 Central Vein 3 Percutaneous H Lovotigeglogene Autotemcel 9 New Technology Group 9 Lovotibeglogene autotemcel (lovo-cel) is an investigational one-time ex vivo gene addition therapy product being evaluated for the treatment of sickle cell disease (SCD). Lovo-cel gene therapy uses autologous transplantation of hematopoietic stem and progenitor cells...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .

Thank you for choosing Find-A-Code, please Sign In to remove ads.